ESMIT Online Courses

Fundamentals of Research in Imaging and Theranostics – Part 1: Research Design

 

Self-paced on-demand course
Online

An application has been made to the UEMS EACCME for CME accreditation of this event.

COURSE CONTENT

This online course is part of a long line of research methodology which is aimed at providing interested participants with information about the preclinical development and clinical translation, as well as the design, conductance and reporting of clinical research trials, with a specific emphasis on radiopharmaceuticals for both diagnostic and therapeutic applications.

These first two modules will represent part one of the course, which will take place in 2022.

Module 1 will focus on the entire path from preclinical development to clinical translation of an imaging compound, including the preclinical studies needed for the selection of a new candidate for clinical translation, an overview of EU legislation on radiopharmaceuticals for diagnosis and therapy, and the assessment of quality data and non-clinical data (pharmacology, dosimetry and toxicology) for the IMP dossier.

Module 2 will be focused on the design of a proper trial. It will cover: the definition of objectives, aims, endpoints, population, statistical methods and examples of trial design schemes, as well as dosimetry as far as healthy organs and in case of therapy tumour-absorbed dose. It will have a special focus on phase 0, phase 1-2 trial, early clinical phase 0-1-2 and investigator-driven clinical trial.


LEARNING OBJECTIVES

The participants will learn about:

  • Preclinical development and clinical translation of radiopharmaceuticals
  • The legislation on radiopharmaceuticals with a specific focus on the European scenario
  • Requirements of IMPD for radiopharmaceuticals for imaging agents and theranostic/therapeutic molecules
  • Interpretation of preclinical data to proper design and plan the clinical trial
  • Phase 0, phase 1 and phase 2 clinical trials with radiopharmaceuticals design
  • Phase 0, phase 1 and phase 2 clinical trials with radiopharmaceuticals conductance
  • GMP, GLP, GCP principles
  • Importance of radioprotection and dosimetric estimates in early phase clinical trials

TARGET AUDIENCE

Researchers, scientists, nurses, pharmacologists, radiopharmacists, residents and specialists in Nuclear Medicine/Oncology/Radiology who want to understand how clinical trials with radiopharmaceuticals in the early phase are unique and how the corresponding documents and trial design should be appropriately planned.


PREPARATORY MATERIAL

No preparatory material.

FACULTY

  • Paola Anna Erba
  • Sona Balogova
  • Elisabeth von Guggenberg
  • Martina Sollini
  • Luigi Aloj
  • Meltem Ocak
  • Peter Laverman
  • Jane Sosabowski
  • Petra Kolenc
  • Clemens Decristoforo
  • Piotr Garnuszek
  • Renata Mikolajczak
  • Theodosia Maina
  • Mark Konijnenberg

PROGRAMME

Click here to view the programme

icon_question_pur HOW TO REGISTER

  1. Access your myEANM account (or create a new one)
  2. Click on the “eLearning Platform” button in the left sidebar menu
  3. Click on “Register Now!” in the horizontal navigation bar
  4. You have now entered the course store and are able to register for the webinar in the Online courses section.

icon_ticket_pur REGISTRATION FEE

Course Fee               € 300 + VAT


icon_payment_pur MODE OF PAYMENT

  • Credit card.
  • Cheques will not be accepted.

 

 

This website uses cookies. Learn more